2021 World Conference on Lung Cancer (Posters)-FP08. Outcomes With Multi-Disciplinary Management of Central Lung Tumors Treated With Percutaneous High-Dose-Rate Brachytherapy

FP08. Outcomes With Multi-Disciplinary Management of Central Lung Tumors Treated With Percutaneous High-Dose-Rate Brachytherapy

Back to course

Video Transcription

Video Summary

The outcomes of using percutaneous high-dose rate brachytherapy for the treatment of centrally located lung tumors are summarized. The study included 25 patients with 37 tumors who were treated with this technique. The treatment was delivered by a multidisciplinary team. The two-year local control and overall survival rates were 96.2% and 65.5% respectively. Four patients experienced acute grade 1 to 2 toxicity, but no late toxicity was observed beyond 90 days follow-up. The study concludes that percutaneous high-dose rate brachytherapy shows promise as a therapeutic option for centrally located lung tumors and encourages further comparisons to established therapies.

Asset Subtitle

Stephanie Mijin Yoon

Meta Tag

Speaker Stephanie Mijin Yoon

Topic Multimodality of Advanced Lung Cancer

Keywords

percutaneous high-dose rate brachytherapy

centrally located lung tumors

treatment outcomes

local control rates

overall survival rates